WO2001055173A8 - Nucleic acids, proteins, and antibodies - Google Patents
Nucleic acids, proteins, and antibodiesInfo
- Publication number
- WO2001055173A8 WO2001055173A8 PCT/US2001/001356 US0101356W WO0155173A8 WO 2001055173 A8 WO2001055173 A8 WO 2001055173A8 US 0101356 W US0101356 W US 0101356W WO 0155173 A8 WO0155173 A8 WO 0155173A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antibodies
- proteins
- nucleic acids
- nucleic
- acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (235)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17906500P | 2000-01-31 | 2000-01-31 | |
| US60/179,065 | 2000-01-31 | ||
| US18062800P | 2000-02-04 | 2000-02-04 | |
| US60/180,628 | 2000-02-04 | ||
| US18466400P | 2000-02-24 | 2000-02-24 | |
| US60/184,664 | 2000-02-24 | ||
| US18635000P | 2000-03-02 | 2000-03-02 | |
| US60/186,350 | 2000-03-02 | ||
| US18987400P | 2000-03-16 | 2000-03-16 | |
| US60/189,874 | 2000-03-16 | ||
| US19007600P | 2000-03-17 | 2000-03-17 | |
| US60/190,076 | 2000-03-17 | ||
| US19812300P | 2000-04-18 | 2000-04-18 | |
| US60/198,123 | 2000-04-18 | ||
| US20551500P | 2000-05-19 | 2000-05-19 | |
| US60/205,515 | 2000-05-19 | ||
| US20946700P | 2000-06-07 | 2000-06-07 | |
| US60/209,467 | 2000-06-07 | ||
| US21488600P | 2000-06-28 | 2000-06-28 | |
| US60/214,886 | 2000-06-28 | ||
| US21513500P | 2000-06-30 | 2000-06-30 | |
| US60/215,135 | 2000-06-30 | ||
| US21664700P | 2000-07-07 | 2000-07-07 | |
| US21688000P | 2000-07-07 | 2000-07-07 | |
| US60/216,647 | 2000-07-07 | ||
| US60/216,880 | 2000-07-07 | ||
| US21749600P | 2000-07-11 | 2000-07-11 | |
| US21748700P | 2000-07-11 | 2000-07-11 | |
| US60/217,487 | 2000-07-11 | ||
| US60/217,496 | 2000-07-11 | ||
| US21829000P | 2000-07-14 | 2000-07-14 | |
| US60/218,290 | 2000-07-14 | ||
| US22096300P | 2000-07-26 | 2000-07-26 | |
| US22096400P | 2000-07-26 | 2000-07-26 | |
| US60/220,964 | 2000-07-26 | ||
| US60/220,963 | 2000-07-26 | ||
| US22544700P | 2000-08-14 | 2000-08-14 | |
| US22451900P | 2000-08-14 | 2000-08-14 | |
| US22521400P | 2000-08-14 | 2000-08-14 | |
| US22575900P | 2000-08-14 | 2000-08-14 | |
| US22526800P | 2000-08-14 | 2000-08-14 | |
| US22451800P | 2000-08-14 | 2000-08-14 | |
| US22521300P | 2000-08-14 | 2000-08-14 | |
| US22526700P | 2000-08-14 | 2000-08-14 | |
| US22575800P | 2000-08-14 | 2000-08-14 | |
| US22575700P | 2000-08-14 | 2000-08-14 | |
| US22526600P | 2000-08-14 | 2000-08-14 | |
| US22527000P | 2000-08-14 | 2000-08-14 | |
| US60/224,518 | 2000-08-14 | ||
| US60/225,757 | 2000-08-14 | ||
| US60/225,267 | 2000-08-14 | ||
| US60/225,268 | 2000-08-14 | ||
| US60/225,758 | 2000-08-14 | ||
| US60/225,214 | 2000-08-14 | ||
| US60/225,213 | 2000-08-14 | ||
| US60/225,447 | 2000-08-14 | ||
| US60/224,519 | 2000-08-14 | ||
| US60/225,266 | 2000-08-14 | ||
| US60/225,270 | 2000-08-14 | ||
| US60/225,759 | 2000-08-14 | ||
| US22627900P | 2000-08-18 | 2000-08-18 | |
| US60/226,279 | 2000-08-18 | ||
| US22718200P | 2000-08-22 | 2000-08-22 | |
| US22686800P | 2000-08-22 | 2000-08-22 | |
| US22668100P | 2000-08-22 | 2000-08-22 | |
| US60/226,868 | 2000-08-22 | ||
| US60/227,182 | 2000-08-22 | ||
| US60/226,681 | 2000-08-22 | ||
| US22700900P | 2000-08-23 | 2000-08-23 | |
| US60/227,009 | 2000-08-23 | ||
| US22892400P | 2000-08-30 | 2000-08-30 | |
| US60/228,924 | 2000-08-30 | ||
| US22934500P | 2000-09-01 | 2000-09-01 | |
| US22934400P | 2000-09-01 | 2000-09-01 | |
| US22934300P | 2000-09-01 | 2000-09-01 | |
| US22928700P | 2000-09-01 | 2000-09-01 | |
| US60/229,344 | 2000-09-01 | ||
| US60/229,345 | 2000-09-01 | ||
| US60/229,343 | 2000-09-01 | ||
| US60/229,287 | 2000-09-01 | ||
| US22950900P | 2000-09-05 | 2000-09-05 | |
| US22951300P | 2000-09-05 | 2000-09-05 | |
| US60/229,509 | 2000-09-05 | ||
| US60/229,513 | 2000-09-05 | ||
| US23043700P | 2000-09-06 | 2000-09-06 | |
| US23043800P | 2000-09-06 | 2000-09-06 | |
| US60/230,437 | 2000-09-06 | ||
| US60/230,438 | 2000-09-06 | ||
| US23124400P | 2000-09-08 | 2000-09-08 | |
| US23208000P | 2000-09-08 | 2000-09-08 | |
| US23141400P | 2000-09-08 | 2000-09-08 | |
| US23141300P | 2000-09-08 | 2000-09-08 | |
| US23124200P | 2000-09-08 | 2000-09-08 | |
| US23124300P | 2000-09-08 | 2000-09-08 | |
| US23208100P | 2000-09-08 | 2000-09-08 | |
| US60/232,080 | 2000-09-08 | ||
| US60/232,081 | 2000-09-08 | ||
| US60/231,413 | 2000-09-08 | ||
| US60/231,242 | 2000-09-08 | ||
| US60/231,244 | 2000-09-08 | ||
| US60/231,414 | 2000-09-08 | ||
| US60/231,243 | 2000-09-08 | ||
| US23196800P | 2000-09-12 | 2000-09-12 | |
| US60/231,968 | 2000-09-12 | ||
| US23306300P | 2000-09-14 | 2000-09-14 | |
| US23306400P | 2000-09-14 | 2000-09-14 | |
| US23239800P | 2000-09-14 | 2000-09-14 | |
| US23306500P | 2000-09-14 | 2000-09-14 | |
| US23240000P | 2000-09-14 | 2000-09-14 | |
| US23239900P | 2000-09-14 | 2000-09-14 | |
| US23240100P | 2000-09-14 | 2000-09-14 | |
| US23239700P | 2000-09-14 | 2000-09-14 | |
| US60/232,398 | 2000-09-14 | ||
| US60/232,400 | 2000-09-14 | ||
| US60/232,401 | 2000-09-14 | ||
| US60/233,064 | 2000-09-14 | ||
| US60/232,399 | 2000-09-14 | ||
| US60/233,065 | 2000-09-14 | ||
| US60/233,063 | 2000-09-14 | ||
| US60/232,397 | 2000-09-14 | ||
| US23427400P | 2000-09-21 | 2000-09-21 | |
| US23422300P | 2000-09-21 | 2000-09-21 | |
| US60/234,274 | 2000-09-21 | ||
| US60/234,223 | 2000-09-21 | ||
| US23499800P | 2000-09-25 | 2000-09-25 | |
| US23499700P | 2000-09-25 | 2000-09-25 | |
| US60/234,997 | 2000-09-25 | ||
| US60/234,998 | 2000-09-25 | ||
| US23548400P | 2000-09-26 | 2000-09-26 | |
| US60/235,484 | 2000-09-26 | ||
| US23583600P | 2000-09-27 | 2000-09-27 | |
| US23583400P | 2000-09-27 | 2000-09-27 | |
| US60/235,836 | 2000-09-27 | ||
| US60/235,834 | 2000-09-27 | ||
| US23636700P | 2000-09-29 | 2000-09-29 | |
| US23636900P | 2000-09-29 | 2000-09-29 | |
| US23637000P | 2000-09-29 | 2000-09-29 | |
| US23636800P | 2000-09-29 | 2000-09-29 | |
| US23632700P | 2000-09-29 | 2000-09-29 | |
| US60/236,327 | 2000-09-29 | ||
| US60/236,367 | 2000-09-29 | ||
| US60/236,370 | 2000-09-29 | ||
| US60/236,368 | 2000-09-29 | ||
| US60/236,369 | 2000-09-29 | ||
| US23703700P | 2000-10-02 | 2000-10-02 | |
| US23704000P | 2000-10-02 | 2000-10-02 | |
| US23680200P | 2000-10-02 | 2000-10-02 | |
| US23703800P | 2000-10-02 | 2000-10-02 | |
| US23703900P | 2000-10-02 | 2000-10-02 | |
| US60/236,802 | 2000-10-02 | ||
| US60/237,039 | 2000-10-02 | ||
| US60/237,037 | 2000-10-02 | ||
| US60/237,040 | 2000-10-02 | ||
| US60/237,038 | 2000-10-02 | ||
| US23993500P | 2000-10-13 | 2000-10-13 | |
| US23993700P | 2000-10-13 | 2000-10-13 | |
| US60/239,937 | 2000-10-13 | ||
| US60/239,935 | 2000-10-13 | ||
| US24178700P | 2000-10-20 | 2000-10-20 | |
| US24180800P | 2000-10-20 | 2000-10-20 | |
| US24182600P | 2000-10-20 | 2000-10-20 | |
| US24122100P | 2000-10-20 | 2000-10-20 | |
| US24178600P | 2000-10-20 | 2000-10-20 | |
| US24178500P | 2000-10-20 | 2000-10-20 | |
| US24096000P | 2000-10-20 | 2000-10-20 | |
| US24180900P | 2000-10-20 | 2000-10-20 | |
| US60/241,826 | 2000-10-20 | ||
| US60/241,221 | 2000-10-20 | ||
| US60/240,960 | 2000-10-20 | ||
| US60/241,808 | 2000-10-20 | ||
| US60/241,809 | 2000-10-20 | ||
| US60/241,785 | 2000-10-20 | ||
| US60/241,786 | 2000-10-20 | ||
| US60/241,787 | 2000-10-20 | ||
| US24461700P | 2000-11-01 | 2000-11-01 | |
| US60/244,617 | 2000-11-01 | ||
| US24661000P | 2000-11-08 | 2000-11-08 | |
| US24652700P | 2000-11-08 | 2000-11-08 | |
| US24653200P | 2000-11-08 | 2000-11-08 | |
| US24661100P | 2000-11-08 | 2000-11-08 | |
| US24647400P | 2000-11-08 | 2000-11-08 | |
| US24652500P | 2000-11-08 | 2000-11-08 | |
| US24647700P | 2000-11-08 | 2000-11-08 | |
| US24647600P | 2000-11-08 | 2000-11-08 | |
| US24652800P | 2000-11-08 | 2000-11-08 | |
| US24652600P | 2000-11-08 | 2000-11-08 | |
| US24647500P | 2000-11-08 | 2000-11-08 | |
| US60/246,475 | 2000-11-08 | ||
| US60/246,613 | 2000-11-08 | ||
| US60/246,610 | 2000-11-08 | ||
| US60/246,528 | 2000-11-08 | ||
| US60/246,476 | 2000-11-08 | ||
| US60/246,524 | 2000-11-08 | ||
| US60/246,525 | 2000-11-08 | ||
| US60/246,474 | 2000-11-08 | ||
| US60/246,523 | 2000-11-08 | ||
| US60/246,477 | 2000-11-08 | ||
| US60/246,527 | 2000-11-08 | ||
| US60/246,611 | 2000-11-08 | ||
| US60/246,609 | 2000-11-08 | ||
| US60/246,478 | 2000-11-08 | ||
| US60/246,526 | 2000-11-08 | ||
| US60/246,532 | 2000-11-08 | ||
| US60/249,245 | 2000-11-17 | ||
| US60/249,300 | 2000-11-17 | ||
| US60/249,264 | 2000-11-17 | ||
| US60/249,212 | 2000-11-17 | ||
| US60/249,209 | 2000-11-17 | ||
| US60/249,210 | 2000-11-17 | ||
| US60/249,244 | 2000-11-17 | ||
| US60/249,297 | 2000-11-17 | ||
| US60/249,215 | 2000-11-17 | ||
| US60/249,299 | 2000-11-17 | ||
| US60/249,213 | 2000-11-17 | ||
| US60/249,217 | 2000-11-17 | ||
| US60/249,207 | 2000-11-17 | ||
| US60/249,265 | 2000-11-17 | ||
| US60/249,218 | 2000-11-17 | ||
| US60/249,211 | 2000-11-17 | ||
| US60/249,208 | 2000-11-17 | ||
| US60/249,216 | 2000-11-17 | ||
| US60/249,214 | 2000-11-17 | ||
| US60/250,391 | 2000-12-01 | ||
| US60/250,160 | 2000-12-01 | ||
| US60/256,719 | 2000-12-05 | ||
| US60/251,988 | 2000-12-05 | ||
| US60/251,030 | 2000-12-05 | ||
| US60/251,479 | 2000-12-06 | ||
| US60/251,868 | 2000-12-08 | ||
| US60/251,856 | 2000-12-08 | ||
| US60/251,869 | 2000-12-08 | ||
| US60/251,989 | 2000-12-08 | ||
| US60/251,990 | 2000-12-08 | ||
| US60/254,097 | 2000-12-11 | ||
| US60/259,678 | 2001-01-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001055173A2 WO2001055173A2 (en) | 2001-08-02 |
| WO2001055173A8 true WO2001055173A8 (en) | 2001-11-29 |
Family
ID=27587117
Family Applications (48)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2001/001358 WO2001055163A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001348 WO2001055368A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001333 WO2001055448A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001344 WO2001055324A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001315 WO2001055311A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001321 WO2001055312A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001322 WO2001055343A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001332 WO2001055318A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001345 WO2001055325A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001326 WO2001055315A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001349 WO2001054474A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001317 WO2001055201A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001306 WO2001055307A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001342 WO2001059064A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001351 WO2001055355A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001301 WO2001055303A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001324 WO2001055314A2 (en) | 2000-01-31 | 2001-01-17 | Digestive system related nucleic acids, proteins and antibodies |
| PCT/US2001/001316 WO2001054473A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001302 WO2001055304A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001353 WO2001055206A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001336 WO2001055204A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001356 WO2001055173A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001330 WO2001055447A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001350 WO2001055350A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001309 WO2001055308A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001355 WO2001055207A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001240 WO2001055302A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001357 WO2001055208A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001312 WO2001054733A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins and antibodies |
| PCT/US2001/001339 WO2001055320A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001314 WO2001055310A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001308 WO2001055364A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001340 WO2001055321A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001311 WO2001055309A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001327 WO2001055203A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001343 WO2001055323A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001239 WO2001055301A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001310 WO2001055387A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001354 WO2001057182A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001338 WO2001055367A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001359 WO2001055328A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001313 WO2001055200A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001335 WO2001055319A2 (en) | 2000-01-31 | 2001-01-17 | Endocrine related nucleic acids, proteins and antibodies |
| PCT/US2001/001325 WO2001055202A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001337 WO2001055205A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001352 WO2001055327A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001328 WO2001055316A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001341 WO2001055322A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
Family Applications Before (21)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2001/001358 WO2001055163A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001348 WO2001055368A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001333 WO2001055448A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001344 WO2001055324A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001315 WO2001055311A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001321 WO2001055312A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001322 WO2001055343A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001332 WO2001055318A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001345 WO2001055325A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001326 WO2001055315A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001349 WO2001054474A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001317 WO2001055201A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001306 WO2001055307A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001342 WO2001059064A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001351 WO2001055355A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001301 WO2001055303A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001324 WO2001055314A2 (en) | 2000-01-31 | 2001-01-17 | Digestive system related nucleic acids, proteins and antibodies |
| PCT/US2001/001316 WO2001054473A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001302 WO2001055304A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001353 WO2001055206A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001336 WO2001055204A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
Family Applications After (26)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2001/001330 WO2001055447A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001350 WO2001055350A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001309 WO2001055308A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001355 WO2001055207A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001240 WO2001055302A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001357 WO2001055208A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001312 WO2001054733A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins and antibodies |
| PCT/US2001/001339 WO2001055320A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001314 WO2001055310A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001308 WO2001055364A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001340 WO2001055321A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001311 WO2001055309A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001327 WO2001055203A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001343 WO2001055323A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001239 WO2001055301A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001310 WO2001055387A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001354 WO2001057182A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001338 WO2001055367A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001359 WO2001055328A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001313 WO2001055200A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001335 WO2001055319A2 (en) | 2000-01-31 | 2001-01-17 | Endocrine related nucleic acids, proteins and antibodies |
| PCT/US2001/001325 WO2001055202A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001337 WO2001055205A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001352 WO2001055327A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001328 WO2001055316A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001341 WO2001055322A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
Country Status (3)
| Country | Link |
|---|---|
| AU (16) | AU2001241405A1 (en) |
| CA (37) | CA2395178A1 (en) |
| WO (48) | WO2001055163A1 (en) |
Families Citing this family (270)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001070982A2 (en) * | 2000-03-23 | 2001-09-27 | Immusol Incorporated | Brca-1 regulators and methods of use |
| WO2002018435A1 (en) * | 2000-08-28 | 2002-03-07 | Human Genome Sciences, Inc. | 18 human secreted proteins |
| US20020137890A1 (en) | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US6706262B1 (en) | 1998-03-18 | 2004-03-16 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US7258860B2 (en) | 1998-03-18 | 2007-08-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6960570B2 (en) | 1998-03-18 | 2005-11-01 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US7579160B2 (en) | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
| NZ508878A (en) | 1998-05-15 | 2003-08-29 | Genentech Inc | IL-17B and IL-17Cactive variants of IL-17 which stimulates epithelial, endothelial and fibroblastic cells |
| US7771719B1 (en) | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
| US6929938B2 (en) | 2001-08-15 | 2005-08-16 | Millennium Pharmaceuticals, Inc. | 25501, a human transferase family member and uses therefor |
| US7141417B1 (en) | 1999-02-25 | 2006-11-28 | Thomas Jefferson University | Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene |
| EP1163252A4 (en) * | 1999-02-25 | 2004-04-07 | Univ Jefferson | Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene |
| WO2000050458A1 (en) * | 1999-02-26 | 2000-08-31 | Smithkline Beecham Corporation | Cloning of a p2y-like 7tm receptor (axor17) |
| CA2365238A1 (en) * | 1999-03-23 | 2000-09-28 | Human Genome Sciences, Inc. | 48 human secreted proteins |
| CA2365601A1 (en) | 1999-03-29 | 2000-10-05 | Kansai Technology Licensing Organization Co., Ltd. | Novel cytidine deaminase |
| EP1637541B1 (en) * | 1999-09-01 | 2010-03-03 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| AU1238201A (en) * | 1999-10-27 | 2001-05-08 | Millennium Pharmaceuticals, Inc. | Novel molecules and the card-related protein family and uses thereof |
| US6893818B1 (en) | 1999-10-28 | 2005-05-17 | Agensys, Inc. | Gene upregulated in cancers of the prostate |
| US7005499B1 (en) * | 1999-11-18 | 2006-02-28 | Genentech, Inc. | Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same |
| EP1878795A3 (en) * | 1999-11-30 | 2008-01-23 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| CA2709291A1 (en) * | 1999-12-01 | 2001-06-07 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| CN1300781A (en) * | 1999-12-22 | 2001-06-27 | 上海博德基因开发有限公司 | Polypeptide-human SHC protein 43 and polynucleotide for coding this polypeptide |
| US20040043397A1 (en) | 2000-01-11 | 2004-03-04 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| AU2001237973B2 (en) | 2000-01-26 | 2006-09-07 | Agensys, Inc. | 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| US6953682B2 (en) | 2000-02-10 | 2005-10-11 | Millennium Pharmaceuticals, Inc. | Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor |
| US7078205B2 (en) | 2000-02-17 | 2006-07-18 | Millennium Pharmaceuticals, Inc. | Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor |
| US20020082212A1 (en) * | 2000-07-20 | 2002-06-27 | Millennium Pharmaceuticals, Inc. | 7716, a novel human ATPase and uses therefor |
| WO2001096542A2 (en) * | 2000-06-15 | 2001-12-20 | Millennium Pharmaceuticals, Inc. | A human aminotransferase (23680) and uses thereof |
| US7718397B2 (en) | 2000-03-21 | 2010-05-18 | Genentech, Inc. | Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
| US20020025931A1 (en) | 2000-03-24 | 2002-02-28 | Rachel Meyers | 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor |
| US20030198953A1 (en) * | 2000-03-30 | 2003-10-23 | Spytek Kimberly A. | Novel proteins and nucleic acids encoding same |
| US7632929B2 (en) | 2000-04-20 | 2009-12-15 | The Board Of Trustees Of The University Of Arkansas | Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof |
| WO2001081557A2 (en) * | 2000-04-25 | 2001-11-01 | Lexicon Genetics Incorporated | Human kinase proteins and polynucleotides encoding the same |
| WO2001081586A2 (en) * | 2000-04-26 | 2001-11-01 | Millennium Pharmaceuticals, Inc. | 21657, a human short-chain dehydrogenase and uses thereof |
| US6808876B1 (en) * | 2000-05-02 | 2004-10-26 | Immusol, Inc. | Cellular regulators of infectious agents and methods of use |
| US20030096313A1 (en) * | 2000-05-12 | 2003-05-22 | Burkhard Scharm | Novel serine-threonine kinase-4 |
| EP1307545A2 (en) * | 2000-05-26 | 2003-05-07 | Bayer Aktiengesellschaft | REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE |
| EP1158001B1 (en) * | 2000-05-26 | 2007-11-14 | F. Hoffmann-La Roche Ag | A nucleic acid which is upregulated in human tumor cells, a protein encoded thereby and a process for tumor diagnosis |
| DE10027170A1 (en) * | 2000-05-31 | 2001-12-13 | Schering Ag | Human PEM as a target for fertility control |
| AU6531101A (en) * | 2000-06-02 | 2001-12-17 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| WO2001093805A2 (en) * | 2000-06-02 | 2001-12-13 | The Brigham & Women's Hospital, Inc. | FUSION OF jAZF1 AND jjAZ1 GENES IN ENDOMETIRIAL STROMAL TUMORS |
| US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| EP1292677A2 (en) * | 2000-06-05 | 2003-03-19 | Bayer Aktiengesellschaft | Human hm74-like g protein coupled receptor |
| JP2004512023A (en) * | 2000-06-09 | 2004-04-22 | コリクサ コーポレイション | Compositions and methods for treatment and diagnosis of colon cancer |
| US6323016B1 (en) | 2000-06-09 | 2001-11-27 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| WO2001096546A2 (en) * | 2000-06-16 | 2001-12-20 | Incyte Genomics, Inc. | Protein phosphatases |
| CA2648048A1 (en) * | 2000-06-23 | 2002-01-03 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| EP1325114A2 (en) * | 2000-06-26 | 2003-07-09 | Millennium Pharmaceuticals, Inc. | A human beta-ketoacyl synthase (46619) and uses thereof |
| JP2004501623A (en) * | 2000-06-27 | 2004-01-22 | キュラジェン コーポレイション | Polynucleotides and polypeptides encoded thereby |
| US7094587B2 (en) | 2000-06-27 | 2006-08-22 | Millennium Pharmaceuticals, Inc. | 16002 Molecules and uses therefor |
| WO2002000939A2 (en) | 2000-06-28 | 2002-01-03 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| WO2002002761A2 (en) * | 2000-06-30 | 2002-01-10 | Millennium Pharmaceuticals, Inc. | 57658, a human uridine kinase and uses thereof |
| WO2002004520A2 (en) * | 2000-07-07 | 2002-01-17 | Incyte Genomics, Inc. | Transporters and ion channels |
| WO2002004510A2 (en) * | 2000-07-07 | 2002-01-17 | Incyte Genomics, Inc. | Gtp-binding proteins |
| AU2001275944A1 (en) * | 2000-07-14 | 2002-01-30 | Millennium Pharmaceuticals, Inc. | 62088, a human nucleoside phosphatase family member and uses thereof |
| US6740751B2 (en) | 2000-07-18 | 2004-05-25 | Board Of Regents, The University Of Texas System | Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| AU2001281967A1 (en) * | 2000-07-18 | 2002-01-30 | Bayer Aktiengesellschaft | Regulation of human desc1-like serine protease |
| JP2004514420A (en) * | 2000-07-20 | 2004-05-20 | ジェネンテック・インコーポレーテッド | Secreted and transmembrane polypeptides and nucleic acids encoding them |
| US20060252034A1 (en) * | 2000-07-25 | 2006-11-09 | Klaus Duecker | Novel protein containing ring finger domaine r1p4 |
| WO2002008282A2 (en) * | 2000-07-26 | 2002-01-31 | Stanford University | Bstp-ras/rerg protein and related reagents and methods of use thereof |
| AU2001277200A1 (en) * | 2000-07-26 | 2002-02-05 | Applied Genomics, Inc. | Bstp-cad protein and related reagents and methods of use thereof |
| US7335732B2 (en) | 2000-08-01 | 2008-02-26 | Genentech, Inc. | PRO9799 polypeptides |
| EP1657254A3 (en) * | 2000-08-01 | 2006-06-07 | Genentech, Inc. | Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
| US7402660B2 (en) | 2000-08-02 | 2008-07-22 | The Johns Hopkins University | Endothelial cell expression patterns |
| EP1315431A1 (en) * | 2000-08-02 | 2003-06-04 | Millennium Pharmaceuticals, Inc. | A human gtp-releasing factor family member (15368) and uses therefor |
| WO2002012330A2 (en) * | 2000-08-04 | 2002-02-14 | Zymogenetics, Inc. | Human secreted protein, zzp1 |
| US6943245B2 (en) | 2000-08-10 | 2005-09-13 | Board Of Regents, The University Of Texas System | Tumor suppressor CAR-1 |
| US7091022B2 (en) * | 2000-08-11 | 2006-08-15 | Merck Patent Gmbh | Mitogen activated kinase |
| EP1326985A1 (en) * | 2000-08-18 | 2003-07-16 | MERCK PATENT GmbH | Identification of a human n-terminal acetyltransferase gene |
| US6706513B2 (en) | 2000-08-21 | 2004-03-16 | Bristol-Myers Squibb Company | Adenosine deaminase homolog |
| JP2004519217A (en) * | 2000-08-21 | 2004-07-02 | インサイト・ゲノミックス・インコーポレイテッド | Microtubule-associated proteins and tubulin |
| WO2002016579A2 (en) * | 2000-08-24 | 2002-02-28 | Eli Lilly And Company | Nucleic acids, vectors, host cells, polypeptides and uses thereof |
| US20040096842A1 (en) * | 2000-08-28 | 2004-05-20 | Peter Brodin | Molecules involved in the regulation of insulin resistance syndrome (irs) |
| ATE403716T1 (en) | 2000-08-28 | 2008-08-15 | Agensys Inc | NUCLEIC ACID AND CORRESPONDING PROTEIN 85P1B3, USEFUL FOR TREATING AND DETECTING CANCER DISEASES |
| AU2001286714A1 (en) * | 2000-08-30 | 2002-03-13 | Millennium Pharmaceuticals, Inc. | 54370, a novel human sulfate transporter and uses therefor |
| AU2001285908A1 (en) * | 2000-08-30 | 2002-03-13 | Bayer Aktiengesellschaft | Regulation of human aminotransferase-like enzyme |
| WO2002018577A2 (en) * | 2000-08-30 | 2002-03-07 | Millennium Pharmaceuticals, Inc. | 48921, a novel human gtp releasing factor and uses therefor |
| WO2002018567A2 (en) * | 2000-08-30 | 2002-03-07 | Bayer Aktiengesellschaft | Regulation of human aminotransferase-like enzyme |
| WO2002018582A2 (en) * | 2000-08-31 | 2002-03-07 | Millennium Pharmaceuticals, Inc. | 62112, a novel human dehydrogenase and uses thereof |
| CA2421588C (en) | 2000-09-05 | 2010-01-26 | Amgen Inc. | Tnf receptor-like molecules and uses thereof |
| WO2002020754A2 (en) * | 2000-09-05 | 2002-03-14 | Incyte Genomics, Inc. | Molecules for diagnostics and therapeutics |
| WO2002020765A2 (en) * | 2000-09-08 | 2002-03-14 | Millennium Pharmaceuticals, Inc. | 38646, a guanine nucleotide exchange factor and uses therefor |
| US6391606B1 (en) * | 2000-09-14 | 2002-05-21 | Pe Corporation | Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| US6372468B1 (en) * | 2000-09-14 | 2002-04-16 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| WO2002029058A2 (en) * | 2000-10-05 | 2002-04-11 | Curagen Corporation | Human proteins, polynucleotides encoding them and methods of using the same |
| AU2002220613A1 (en) * | 2000-10-11 | 2002-04-22 | Bayer Aktiengesellschaft | Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase |
| EP1402010A2 (en) * | 2000-10-11 | 2004-03-31 | Millennium Pharmaceuticals, Inc. | 8843, a human dual specificity phosphatase family member and uses therefor |
| US20020064831A1 (en) * | 2000-10-12 | 2002-05-30 | The Texas A&M University System | Nucleic acid sequences encoding CMG proteins, CMG proteins, and methods for their use |
| WO2002030268A2 (en) * | 2000-10-13 | 2002-04-18 | Eos Biotechnology, Inc. | Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| US6531297B2 (en) * | 2000-10-20 | 2003-03-11 | Applera Corporation | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| EP1385861A2 (en) | 2000-10-25 | 2004-02-04 | Diadexus, Inc. | Compositions and methods relating to lung specific genes and proteins |
| AU2002220668A1 (en) * | 2000-10-31 | 2002-05-15 | Bayer Aktiengesellschaft | Regulation of human glutathione-s-transferase |
| WO2002038743A2 (en) * | 2000-11-09 | 2002-05-16 | Glaxo Group Limited | Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp |
| AU2002219988A1 (en) | 2000-11-20 | 2002-05-27 | Diadexus, Inc. | Compositions and methods relating to breast specific genes and proteins |
| AU2001297765A1 (en) * | 2000-12-05 | 2002-10-21 | Incyte Genomics, Inc. | Ligases |
| CA2429959A1 (en) | 2000-12-07 | 2002-06-13 | Zymogenetics, Inc. | Adipocyte complement related protein zacrp3x2 |
| AU2002227365A1 (en) | 2000-12-07 | 2002-06-18 | Chiron Corporation | Endogenous retroviruses up-regulated in prostate cancer |
| CA2439800A1 (en) * | 2000-12-14 | 2002-06-20 | Pe Corporation (Ny) | Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof |
| US20020142376A1 (en) * | 2000-12-20 | 2002-10-03 | Gennady Merkulov | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| US7892730B2 (en) * | 2000-12-22 | 2011-02-22 | Sagres Discovery, Inc. | Compositions and methods for cancer |
| ES2265389T3 (en) | 2000-12-22 | 2007-02-16 | Bristol-Myers Squibb Company | HUMAN PROTEIN CONTAINING REPETITIONS RICH IN LEUCINE EXPRESSED PREDOMINANTLY IN THE INTESTINE DELGADO, HLRRSI1. |
| US6423521B1 (en) | 2000-12-28 | 2002-07-23 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| WO2002053591A1 (en) * | 2000-12-30 | 2002-07-11 | Lion Bioscience Ag | Mammalian nuclear receptor cofactor cf12 and methods of use |
| WO2002053754A2 (en) * | 2001-01-08 | 2002-07-11 | Lexicon Genetics Incorporated | Human protease and polynucleotides encoding the same |
| AU2002243750A1 (en) * | 2001-01-30 | 2002-08-12 | Regeneron Pharmaceuticals, Inc. | Novel nucleic acid and polypeptide molecules |
| CA2438571A1 (en) * | 2001-02-12 | 2002-12-12 | Curagen Corporation | Novel proteins and nucleic acids encoding same |
| EP1637601A3 (en) * | 2001-02-21 | 2006-03-29 | Curagen Corporation | Proteins, polynucleotides encoding them and methods of using the same |
| US7271240B2 (en) | 2001-03-14 | 2007-09-18 | Agensys, Inc. | 125P5C8: a tissue specific protein highly expressed in various cancers |
| AU2002250143A1 (en) * | 2001-03-16 | 2002-10-03 | Eli Lilly And Company | Lp mammalian proteins; related reagents |
| US6913904B2 (en) * | 2001-03-27 | 2005-07-05 | Applera Corporation | Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| AU2002303340A1 (en) | 2001-04-10 | 2002-10-28 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| US20040003418A1 (en) | 2001-04-10 | 2004-01-01 | Aya Jakobovits | Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
| WO2002083921A2 (en) | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| WO2002086113A2 (en) * | 2001-04-24 | 2002-10-31 | Isis Innovation Ltd | Enzyme and snp marker for disease |
| US20040175763A1 (en) * | 2001-04-24 | 2004-09-09 | Hiroshi Saito | Crohn's disease antibody-binding peptide and method of examining crohn's disease |
| EP1391512A4 (en) | 2001-05-07 | 2007-02-14 | Shionogi & Co | Polypeptide serving as angiogenic marker and dna thereof |
| AU2002314048A1 (en) * | 2001-05-09 | 2002-11-18 | Bayer Aktiengesellschaft | Regulation of human phosphatidic acid phosphatase type 2c-like protein |
| US7157558B2 (en) | 2001-06-01 | 2007-01-02 | Genentech, Inc. | Polypeptide encoded by a polynucleotide overexpresses in tumors |
| US7235358B2 (en) | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
| AU2002311535A1 (en) * | 2001-06-26 | 2003-01-08 | Decode Genetics Ehf. | Nucleic acids encoding protein kinases |
| GB2399086A (en) * | 2001-08-02 | 2004-09-08 | Aeomica Inc | Human zinc finger containing gene MDZ4 |
| AU2002359242A1 (en) * | 2001-08-17 | 2003-04-22 | Incyte Genomics, Inc. | Intracellular signaling molecules |
| US7270960B2 (en) * | 2001-08-29 | 2007-09-18 | Pacific Northwest Research Institute | Diagnosis of ovarian carcinomas |
| WO2003023063A1 (en) * | 2001-09-07 | 2003-03-20 | Sankyo Company, Limited | Method of judging onset risk of diabetes |
| WO2003040369A2 (en) * | 2001-09-17 | 2003-05-15 | Molecular Engines Laboratories | Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines |
| WO2003025175A2 (en) * | 2001-09-17 | 2003-03-27 | Molecular Engines Laboratories | Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| WO2003029411A2 (en) | 2001-09-28 | 2003-04-10 | Brigham Young University | Novel cyclooxygenase variants and methods of use |
| EP1439225A4 (en) | 2001-10-04 | 2005-10-26 | Kansai Tech Licensing Org Co | Dr5 gene promoter and siah-1 gene promoter |
| US7084257B2 (en) | 2001-10-05 | 2006-08-01 | Amgen Inc. | Fully human antibody Fab fragments with human interferon-gamma neutralizing activity |
| WO2003031607A1 (en) * | 2001-10-10 | 2003-04-17 | Bayer Healthcare Ag | Regulation of human short-chain dehydrogenase/reductase |
| DE60220621T2 (en) | 2001-11-09 | 2008-03-06 | Proteologics, Inc. | Posh nucleic acid, polypeptides and related methods |
| US7491690B2 (en) | 2001-11-14 | 2009-02-17 | Northwestern University | Self-assembly and mineralization of peptide-amphiphile nanofibers |
| US20050053940A1 (en) * | 2001-11-21 | 2005-03-10 | Joh-E Ikeda | Huntington's disease gene transcriptional factors |
| US7151162B2 (en) | 2001-12-06 | 2006-12-19 | The University Of Children's Hospital Of Both Cantons Of Basel | Nuclear protein |
| WO2003051911A2 (en) * | 2001-12-19 | 2003-06-26 | Genset S.A. | Gmg-5 polynucleotides and polypeptides and uses thereof |
| JP2003245084A (en) * | 2001-12-20 | 2003-09-02 | Morinaga Milk Ind Co Ltd | New gene useful for diagnosis and treatment of aplasia of corpus callosum and aspermatogenesis and use thereof |
| DE10163467A1 (en) * | 2001-12-21 | 2003-11-27 | Axaron Bioscience Ag | New DNA sequence encoding protein 24B2, useful for treatment and diagnosis or cancer and degenerative diseases, also related polypeptides and modulators |
| US6759222B2 (en) | 2002-01-02 | 2004-07-06 | Millennium Pharmaceuticals, Inc. | 14815, a human kinase family member and uses therefor |
| WO2003057870A1 (en) * | 2002-01-07 | 2003-07-17 | Bayer Healthcare Ag | Human phosphatidic acid phosphatase type 2-like protein |
| WO2003059948A1 (en) * | 2002-01-15 | 2003-07-24 | Medigene Ag | Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes |
| WO2003060109A2 (en) * | 2002-01-15 | 2003-07-24 | Bayer Healthcare Ag | Human subtilisin/kexin-like convertase |
| JPWO2003062429A1 (en) * | 2002-01-23 | 2005-05-26 | 山之内製薬株式会社 | New serine protease |
| AU2003215280A1 (en) | 2002-02-15 | 2003-09-09 | Northwestern University | Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
| EP1338609A1 (en) * | 2002-02-21 | 2003-08-27 | MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln | A further KDR receptor and the use thereof |
| WO2003076645A2 (en) * | 2002-03-05 | 2003-09-18 | Applera Corporation | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| WO2003074557A1 (en) * | 2002-03-06 | 2003-09-12 | Oxford Glycosciences (Uk) Ltd | Novel b-cell malignancy-associated protein |
| ATE529535T1 (en) | 2002-03-13 | 2011-11-15 | Genomic Health Inc | GENE EXPRESSION PROFILING IN TUMOR TISSUE SUBJECT TO BIOPSY |
| US7527935B2 (en) | 2002-03-19 | 2009-05-05 | Mitsubishi Tanabe Pharma Corporation | G-protein coupled receptor having eicosanoid as ligand and gene thereof |
| WO2003078466A1 (en) * | 2002-03-19 | 2003-09-25 | Tanabe Seiyaku Co., Ltd. | Novel g protein-coupled recepotrs and genes thereof |
| GB0206684D0 (en) * | 2002-03-21 | 2002-05-01 | Babraham Inst | Novel proteins |
| US7193069B2 (en) * | 2002-03-22 | 2007-03-20 | Research Association For Biotechnology | Full-length cDNA |
| US7329502B2 (en) | 2002-04-25 | 2008-02-12 | The United States Of America As Represented By The Department Of Health And Human Services | ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) |
| JP2004041003A (en) * | 2002-05-17 | 2004-02-12 | Takeda Chem Ind Ltd | New protein, its dna and use thereof |
| JP2005527614A (en) | 2002-05-29 | 2005-09-15 | デヴェロゲン アクチエンゲゼルシャフト フュア エントヴィックルングスビオローギッシェ フォルシュング | Pancreas-specific protein |
| WO2003101401A2 (en) | 2002-06-03 | 2003-12-11 | Chiron Corporation | Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer |
| EP1513934B1 (en) | 2002-06-06 | 2011-03-02 | Oncotherapy Science, Inc. | Genes and polypeptides relating to human colon cancers |
| EP2302039A1 (en) | 2002-06-13 | 2011-03-30 | Novartis Vaccines and Diagnostics, Inc. | Virus-like particles comprising HML-2 gag polypeptide |
| JPWO2004009626A1 (en) * | 2002-07-22 | 2005-11-17 | アステラス製薬株式会社 | Rheumatoid arthritis-related novel gene |
| ATE419360T1 (en) | 2002-08-14 | 2009-01-15 | Nat Inst Of Advanced Ind Scien | NEW N-ACETYL GALACTOSAMINE TRANSFERASES AND NUCLEIC ACIDS ENCODING THEM |
| US20040081653A1 (en) * | 2002-08-16 | 2004-04-29 | Raitano Arthur B. | Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer |
| WO2004018518A1 (en) * | 2002-08-23 | 2004-03-04 | Japan Science And Technology Agency | Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof |
| US20060292564A1 (en) * | 2002-08-27 | 2006-12-28 | Epigenomics Ag | Method and nucleic acids for the analysis of breast cell proliferative disorders |
| US7452969B2 (en) | 2002-08-30 | 2008-11-18 | Licentia Ltd | Neurotrophic factor protein and uses thereof |
| DE60325628D1 (en) | 2002-09-30 | 2009-02-12 | Oncotherapy Science Inc | GENES AND POLYPEPTIDES IN CONNECTION WITH HUMAN PANCREATIC CARCINOMAS |
| EP1552310A2 (en) * | 2002-10-17 | 2005-07-13 | EVOTEC Neurosciences GmbH | Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylyltransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases |
| AU2002952216A0 (en) * | 2002-10-23 | 2002-11-07 | The Walter And Eliza Hall Institute Of Medical Research | Novel therapeutic molecules |
| US7554021B2 (en) | 2002-11-12 | 2009-06-30 | Northwestern University | Composition and method for self-assembly and mineralization of peptide amphiphiles |
| EP1570080A4 (en) | 2002-11-15 | 2006-03-01 | Genomic Health Inc | Gene expression profiling of egfr positive cancer |
| DE10254601A1 (en) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Gene products differentially expressed in tumors and their use |
| AU2002953341A0 (en) * | 2002-12-13 | 2003-01-09 | The Walter And Eliza Hall Institute Of Medical Research | A novel phosphoprotein |
| AU2003287764B2 (en) * | 2002-12-13 | 2010-01-21 | The Walter And Eliza Hall Institute Of Medical Research | A novel phosphoprotein |
| US20040231909A1 (en) | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
| WO2004070025A2 (en) * | 2003-02-05 | 2004-08-19 | Juan Saus | Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
| EP1445614A1 (en) * | 2003-02-06 | 2004-08-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | A method for the in vitro assessment of the progression status of an HIV virus in an invidual |
| US7074891B2 (en) * | 2003-02-07 | 2006-07-11 | Posco | Leukocyte stimulating peptides |
| ES2314378T3 (en) | 2003-02-20 | 2009-03-16 | Genomic Health, Inc. | USE OF INTRONIC RNA TO MEASURE GENE EXPRESSION. |
| JPWO2004078784A1 (en) * | 2003-03-04 | 2006-06-08 | アステラス製薬株式会社 | Novel genes related to fibrotic conditions |
| US7785829B2 (en) | 2003-03-19 | 2010-08-31 | Biogen Idec Ma, Inc. | Nogo receptor binding protein |
| ITRM20030149A1 (en) | 2003-04-02 | 2004-10-03 | Giuliani Spa | ANTISENSE OLIGONUCLEOTIDES (ODN) FOR SMAD7 AND THEIR USE IN THE MEDICAL FIELD |
| ES2609234T3 (en) | 2003-06-24 | 2017-04-19 | Genomic Health, Inc. | Prediction of the probability of cancer recurrence |
| US7526387B2 (en) | 2003-07-10 | 2009-04-28 | Genomic Health, Inc. | Expression profile algorithm and test for cancer prognosis |
| EP1652923B1 (en) | 2003-08-08 | 2011-10-12 | Perseus Proteomics Inc. | Gene overexpressed in cancer |
| WO2005018554A2 (en) * | 2003-08-12 | 2005-03-03 | Washington University In St. Louis | Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy |
| US20070178458A1 (en) * | 2003-09-05 | 2007-08-02 | O'brien Philippa | Methods of diagnosis and prognosis of ovarian cancer II |
| WO2005026314A2 (en) * | 2003-09-10 | 2005-03-24 | Japan Science And Technology Agency | Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same |
| ES2346314T3 (en) * | 2003-10-02 | 2010-10-14 | Glaxosmithkline Biolog Sa | ANTIGENS OF B. PERTUSSIS AND USE OF THE SAME IN VACCINATION. |
| KR20060089732A (en) | 2003-10-03 | 2006-08-09 | 브라이엄 앤드 위민즈 하스피틀 | Tim-3 ligands and methods thereof |
| WO2005040791A2 (en) * | 2003-10-21 | 2005-05-06 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with somatostatin- and angiogenin-like peptide receptor (salpr) |
| US20050255560A1 (en) * | 2003-11-21 | 2005-11-17 | Zeren Gao | Ztnf11, a tumor necrosis factor |
| AU2004296181A1 (en) * | 2003-12-05 | 2005-06-23 | Northwestern University | Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| US20050196782A1 (en) | 2003-12-23 | 2005-09-08 | Kiefer Michael C. | Universal amplification of fragmented RNA |
| US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
| PL3296407T3 (en) * | 2004-03-02 | 2019-11-29 | Univ Johns Hopkins | Mutations of the pik3ca gene in human cancers |
| TW200539890A (en) | 2004-03-12 | 2005-12-16 | Brigham & Womens Hospital | Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| WO2005090569A1 (en) * | 2004-03-24 | 2005-09-29 | The Council Of The Queensland Institute Of Medical Research | Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof |
| KR101204286B1 (en) | 2004-03-30 | 2012-11-26 | 엔에스진 에이/에스 | Therapeutic use of a growth factor, NsG33 |
| CA2563074C (en) | 2004-04-09 | 2014-05-20 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
| DE102004024617A1 (en) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentially expressed in tumors gene products and their use |
| WO2005118832A2 (en) * | 2004-06-01 | 2005-12-15 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase-like protein (sgkl) |
| EP1776136B1 (en) | 2004-06-24 | 2012-10-03 | Biogen Idec MA Inc. | Treatment of conditions involving demyelination |
| US7587279B2 (en) | 2004-07-06 | 2009-09-08 | Genomic Health | Method for quantitative PCR data analysis system (QDAS) |
| CN101654474B (en) * | 2004-08-05 | 2012-11-07 | 东亚合成株式会社 | Crohn's disease antibody epitope peptide and reagent for testing crohn's disease |
| US7622251B2 (en) | 2004-11-05 | 2009-11-24 | Genomic Health, Inc. | Molecular indicators of breast cancer prognosis and prediction of treatment response |
| US7930104B2 (en) | 2004-11-05 | 2011-04-19 | Genomic Health, Inc. | Predicting response to chemotherapy using gene expression markers |
| EP2325206B1 (en) | 2004-11-12 | 2014-03-19 | Xencor, Inc. | Fc variants with altered binding to fcrn |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| CA2598251A1 (en) | 2005-03-04 | 2006-09-14 | Northwestern University | Angiogenic heparin binding peptide amphiphiles |
| US8497101B2 (en) * | 2005-05-13 | 2013-07-30 | Centre National De La Recherche Scientifique (Cnrs) | Use of a new gene coding for a new member of the MCM2-8 family in pharmaceutical compositions |
| BRPI0613387A2 (en) | 2005-07-08 | 2011-01-11 | Biogen Idec Inc | isolated antibody or antigen binding fragment thereof and its use, isolated polynucleotide, composition, vector, host cell, anti-sp35 antibody and method for producing the same, isolated polypeptide, in vitro method for reducing inhibition of axonal growth and in vitro method for inhibiting cone collapse growth |
| WO2007014338A2 (en) * | 2005-07-26 | 2007-02-01 | Siemens Medical Solutions Diagnostics | Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease |
| US8207128B2 (en) * | 2005-09-28 | 2012-06-26 | Supadelixir Inc. | Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof |
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| ATE480559T1 (en) | 2005-12-14 | 2010-09-15 | Licentia Ltd | USES OF A NEUROTROPHIC FACTOR |
| WO2008003656A2 (en) * | 2006-07-03 | 2008-01-10 | Exonhit Therapeutics Sa | Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
| CA2662915A1 (en) * | 2006-09-08 | 2008-03-13 | Corixa Corporation | Methods, compositions, and kits for the detection and monitoring of colon cancer |
| US8076295B2 (en) | 2007-04-17 | 2011-12-13 | Nanotope, Inc. | Peptide amphiphiles having improved solubility and methods of using same |
| US8999634B2 (en) * | 2007-04-27 | 2015-04-07 | Quest Diagnostics Investments Incorporated | Nucleic acid detection combining amplification with fragmentation |
| GB0805159D0 (en) * | 2008-03-19 | 2008-04-23 | Sancho Madrid David | Immune modulation via C-type lectin |
| PL2562183T3 (en) * | 2007-07-27 | 2016-03-31 | Immatics Biotechnologies Gmbh | Novel immunogenic epitopes for immunotherapy |
| US7863021B2 (en) | 2007-09-05 | 2011-01-04 | Celera Corporation | Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof |
| WO2009034661A1 (en) * | 2007-09-12 | 2009-03-19 | Toppan Printing Co., Ltd. | Method for diagnosis and induction of resistance to virus |
| US8354273B2 (en) | 2007-10-17 | 2013-01-15 | Universidad De Cordoba | Isoforms of human somatostatin receptor type 5 |
| PL2235059T3 (en) | 2007-12-26 | 2015-08-31 | Xencor Inc | Fc variants with altered binding to fcrn |
| GB0803352D0 (en) | 2008-02-22 | 2008-04-02 | Ntnu Technology Transfer As | Oligopeptidic compounds and uses thereof |
| ES2584438T3 (en) * | 2008-03-21 | 2016-09-27 | Universiteit Hasselt | Biomarkers for rheumatoid arthritis |
| AU2009269099B2 (en) | 2008-07-09 | 2016-03-10 | Biogen Ma Inc. | Compositions comprising antibodies to LINGO or fragments thereof |
| CA2730710C (en) | 2008-07-24 | 2021-06-08 | Nsgene A/S | Therapeutic use of a growth factor, metrnl |
| DK2172211T3 (en) | 2008-10-01 | 2015-02-16 | Immatics Biotechnologies Gmbh | Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers |
| EP2358908B1 (en) | 2008-11-14 | 2014-01-08 | Gen-Probe Incorporated | Compositions and methods for detection of campylobacter nucleic acid |
| WO2010062960A2 (en) | 2008-11-26 | 2010-06-03 | Cedars-Sinai Medical Center | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE |
| WO2010066018A1 (en) * | 2008-12-09 | 2010-06-17 | Alethia Biotherapeutics Inc. | Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer |
| MX2011010780A (en) | 2009-04-13 | 2011-10-28 | Univ Northwestern | Novel peptide-based scaffolds for cartilage regeneration and methods for their use. |
| US9493578B2 (en) | 2009-09-02 | 2016-11-15 | Xencor, Inc. | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens |
| WO2011094445A1 (en) * | 2010-01-27 | 2011-08-04 | Massachusetts Institute Of Technology | Engineered polypeptide agents for targeted broad spectrum influenza neutralization |
| PT3409287T (en) | 2010-09-29 | 2021-05-27 | Agensys Inc | Antibody drug conjugates (adc) that bind to 191p4d12 proteins |
| KR101886029B1 (en) | 2010-10-01 | 2018-08-07 | 호바 세라퓨틱스 에이피에스 | Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
| WO2012081040A1 (en) * | 2010-12-14 | 2012-06-21 | Hananja Ehf. | Biological activity of placental protein 13 |
| KR102075881B1 (en) | 2011-09-05 | 2020-02-11 | 호바 세라퓨틱스 에이피에스 | Treatment of allodynia, hyperalgsia, spontaneous pain, and phantom pain |
| WO2013068445A1 (en) * | 2011-11-09 | 2013-05-16 | Sanofi | Diacylglycerol lipase and uses thereof |
| US8815247B2 (en) | 2012-04-30 | 2014-08-26 | Biocon Limited | Targeted/immunomodulatory fusion proteins |
| WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
| AU2013262934B2 (en) | 2012-05-14 | 2018-02-01 | Biogen Ma Inc. | LINGO-2 antagonists for treatment of conditions involving motor neurons |
| WO2013174404A1 (en) | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| KR20240033145A (en) | 2012-11-13 | 2024-03-12 | 비온테크 에스이 | Agents for treatment of claudin expressing cancer diseases |
| WO2014127785A1 (en) | 2013-02-20 | 2014-08-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| US9023353B2 (en) * | 2013-03-13 | 2015-05-05 | The Board Of Trustees Of The University Of Arkansas | Anti-(+)—methamphetamine monoclonal antibodies |
| WO2014146672A1 (en) | 2013-03-18 | 2014-09-25 | Ganymed Pharmaceuticals Ag | Therapy involving antibodies against claudin 18.2 for treatment of cancer |
| KR102343212B1 (en) | 2013-03-27 | 2021-12-23 | 세다르스-신나이 메디칼 센터 | Mitigation and reversal of fibrosis and inflammation by inhibition of tl1a function and related signaling pathways |
| PL3019619T3 (en) | 2013-07-11 | 2022-01-10 | Modernatx, Inc. | Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use |
| EP4105236A1 (en) | 2013-07-19 | 2022-12-21 | Cedars-Sinai Medical Center | Anti-tl1a (tnfsf15) antibody for treatment of inflammatory bowel disease |
| US20150087810A1 (en) | 2013-09-25 | 2015-03-26 | Cytomx Therapeutics, Inc. | Matrix Metalloproteinase Substrates And Other Cleavable Moieties And Methods Of Use Thereof |
| JP6558699B2 (en) | 2013-10-01 | 2019-08-14 | 国立大学法人三重大学 | T cell-derived vaccine containing an inter-epitope sequence that promotes antigen presentation |
| CA2937370A1 (en) | 2014-01-31 | 2015-08-06 | Cytomx Therapeutics, Inc. | Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof |
| CA2973266A1 (en) | 2015-01-08 | 2016-07-14 | Biogen Ma Inc. | Lingo-1 antagonists and uses for treatment of demyelinating disorders |
| MA41374A (en) | 2015-01-20 | 2017-11-28 | Cytomx Therapeutics Inc | MATRIX METALLOPROTEASE CLIVABLE AND SERINE PROTEASE CLIVABLE SUBSTRATES AND METHODS OF USE THEREOF |
| WO2016201077A1 (en) * | 2015-06-12 | 2016-12-15 | Emory University | Growth and survival compositions for cells capable of producing antibodies and methods related thereto |
| PT3344776T (en) | 2015-09-04 | 2021-08-03 | Synthetic Genomics Inc | Microorganisms engineered for increased productivity |
| EP3430172A4 (en) | 2016-03-17 | 2019-08-21 | Cedars-Sinai Medical Center | Methods of diagnosing inflammatory bowel disease through rnaset2 |
| EP3436069A4 (en) * | 2016-03-29 | 2019-12-18 | Valkyrie Therapeutics Inc. | Modulation of structural maintenance of chromosome-1 expression |
| US9611297B1 (en) | 2016-08-26 | 2017-04-04 | Thrasos Therapeutics Inc. | Compositions and methods for the treatment of cast nephropathy and related conditions |
| US11125757B2 (en) | 2017-05-26 | 2021-09-21 | Emory University | Methods of culturing and characterizing antibody secreting cells |
| EP3508499A1 (en) | 2018-01-08 | 2019-07-10 | iOmx Therapeutics AG | Antibodies targeting, and other modulators of, an immunoglobulin gene associated with resistance against anti-tumour immune responses, and uses thereof |
| EP3994171A1 (en) | 2019-07-05 | 2022-05-11 | iOmx Therapeutics AG | Antibodies binding igc2 of igsf11 (vsig3) and uses thereof |
| WO2021083958A1 (en) * | 2019-10-29 | 2021-05-06 | Specialites Pet Food | Novel peptides inducing satiety |
| WO2021228999A1 (en) * | 2020-05-12 | 2021-11-18 | Institut Curie | Neoantigenic epitopes associated with sf3b1 mutations |
| WO2022008027A1 (en) | 2020-07-06 | 2022-01-13 | Iomx Therapeutics Ag | Antibodies binding igv of igsf11 (vsig3) and uses thereof |
| EP4281469A1 (en) * | 2021-01-21 | 2023-11-29 | Erasmus University Rotterdam Medical Center | T cells for use in therapy |
| US20220260597A1 (en) * | 2021-02-18 | 2022-08-18 | Beren Therapeutics P.B.C. | Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins |
| WO2023225602A1 (en) * | 2022-05-20 | 2023-11-23 | Medikine, Inc. | Interleukin-18 receptor binding polypeptides and uses thereof |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4446240A (en) * | 1981-01-30 | 1984-05-01 | Nerenberg Samuel T | Pancreas specific protein systems |
| US5457038A (en) * | 1988-11-10 | 1995-10-10 | Genetics Institute, Inc. | Natural killer stimulatory factor |
| US6080540A (en) * | 1990-04-20 | 2000-06-27 | Cold Spring Harbor Laboratory | Cloning of mammalian genes in microbial organisms and methods for pharmacological screening |
| JP2845623B2 (en) * | 1990-11-26 | 1999-01-13 | アメリカ合衆国 | Cellular stress transcription factor |
| US5721352A (en) * | 1991-02-19 | 1998-02-24 | University Of Florida Research Foundation | Entomopoxvirus expression system |
| US5840870A (en) * | 1995-12-29 | 1998-11-24 | Incyte Pharmaceuticals, Inc. | Polynucleotides PANC1A and PANC1B associated with pancreatic cancer |
| WO1999014234A2 (en) * | 1997-09-17 | 1999-03-25 | Genentech, Inc. | Promotion or inhibition of angiogenesis and cardiovascularization |
| WO1997007827A1 (en) * | 1995-08-22 | 1997-03-06 | Thomas Jefferson University | Gab1, A Grb2 BINDING PROTEIN, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME |
| JP3462313B2 (en) * | 1995-08-24 | 2003-11-05 | キッコーマン株式会社 | Mutant uricase, mutant uricase gene, novel recombinant DNA, and method for producing mutant uricase |
| US5998165A (en) * | 1995-12-29 | 1999-12-07 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a protein associated with pancreatic cancer |
| AU721105B2 (en) * | 1996-04-29 | 2000-06-22 | Johns Hopkins University School Of Medicine, The | Mammalian regulator of nonsense-mediated RNA decay |
| US6500934B1 (en) * | 1996-07-24 | 2002-12-31 | Michael Rush Lerner | Bivalent agonists for G-protein coupled receptors |
| US5976834A (en) * | 1997-01-09 | 1999-11-02 | Smithkline Beecham Corporation | cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor |
| US5925521A (en) * | 1997-03-31 | 1999-07-20 | Incyte Pharmaceuticals, Inc. | Human serine carboxypeptidase |
| CA2232743A1 (en) * | 1997-04-02 | 1998-10-02 | Smithkline Beecham Corporation | A tnf homologue, tl5 |
| EP0973898A2 (en) * | 1997-04-10 | 2000-01-26 | Genetics Institute, Inc. | SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
| IT1291110B1 (en) * | 1997-04-15 | 1998-12-29 | Istituto Europ Di Oncologia S | INTRACELLULAR INTERACTORS AND BINDING SPECIFICITY OF THE DOMAIN EH |
| US5948641A (en) * | 1997-05-29 | 1999-09-07 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a metal response element binding protein |
| EP1012292A1 (en) * | 1997-06-06 | 2000-06-28 | Regeneron Pharmaceuticals, Inc. | Ntn-2 member of tnf ligand family |
| US5932442A (en) * | 1997-09-23 | 1999-08-03 | Incyte Pharmaceuticals, Inc. | Human regulatory molecules |
| US5972660A (en) * | 1997-10-22 | 1999-10-26 | Incyte Pharmaceuticals, Inc. | Human hydroxypyruvate reductase |
| DE19818598A1 (en) * | 1998-04-19 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | New nucleic acid sequences expressed in normal pancreatic tissues, and derived polypeptides, for treatment of pancreatic cancer and identification of therapeutic agents |
| NZ507728A (en) * | 1998-04-29 | 2002-06-28 | Genesis Res & Dev Corp Ltd | Information from a cDNA library created from keratinocytes, dermal papilla, neonatal foreskin fibroblast or embryonic skin cells is used to treating cancer, angiogenesis, skin inflammation, inflammatory diseases or stimulating keratinocyte growth |
| US6262249B1 (en) * | 1998-06-23 | 2001-07-17 | Chiron Corporation | Pancreatic cancer genes |
| CA2296792A1 (en) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
-
2001
- 2001-01-17 WO PCT/US2001/001358 patent/WO2001055163A1/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001348 patent/WO2001055368A1/en active Search and Examination
- 2001-01-17 CA CA002395178A patent/CA2395178A1/en not_active Withdrawn
- 2001-01-17 CA CA002395398A patent/CA2395398A1/en not_active Withdrawn
- 2001-01-17 AU AU2001241405A patent/AU2001241405A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001333 patent/WO2001055448A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001344 patent/WO2001055324A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001315 patent/WO2001055311A2/en active Search and Examination
- 2001-01-17 CA CA002395734A patent/CA2395734A1/en not_active Withdrawn
- 2001-01-17 CA CA002392450A patent/CA2392450A1/en not_active Abandoned
- 2001-01-17 CA CA002392428A patent/CA2392428A1/en not_active Abandoned
- 2001-01-17 CA CA002392422A patent/CA2392422A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001321 patent/WO2001055312A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001322 patent/WO2001055343A1/en active Search and Examination
- 2001-01-17 AU AU2001241416A patent/AU2001241416A1/en not_active Abandoned
- 2001-01-17 CA CA002397839A patent/CA2397839A1/en not_active Withdrawn
- 2001-01-17 CA CA002395724A patent/CA2395724A1/en active Pending
- 2001-01-17 CA CA002394841A patent/CA2394841A1/en not_active Withdrawn
- 2001-01-17 CA CA002395729A patent/CA2395729A1/en active Pending
- 2001-01-17 AU AU2001241413A patent/AU2001241413A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001332 patent/WO2001055318A2/en active Search and Examination
- 2001-01-17 AU AU2001241418A patent/AU2001241418A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001345 patent/WO2001055325A2/en active Search and Examination
- 2001-01-17 CA CA002393912A patent/CA2393912A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001326 patent/WO2001055315A2/en active Search and Examination
- 2001-01-17 CA CA002395816A patent/CA2395816A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001349 patent/WO2001054474A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001317 patent/WO2001055201A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001306 patent/WO2001055307A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001342 patent/WO2001059064A2/en active Search and Examination
- 2001-01-17 CA CA002397407A patent/CA2397407A1/en not_active Withdrawn
- 2001-01-17 CA CA002398877A patent/CA2398877A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001351 patent/WO2001055355A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001301 patent/WO2001055303A2/en not_active Application Discontinuation
- 2001-01-17 CA CA002393618A patent/CA2393618A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001324 patent/WO2001055314A2/en active Search and Examination
- 2001-01-17 AU AU2001241407A patent/AU2001241407A1/en not_active Abandoned
- 2001-01-17 CA CA002395858A patent/CA2395858A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001316 patent/WO2001054473A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001302 patent/WO2001055304A2/en active Search and Examination
- 2001-01-17 AU AU2001241415A patent/AU2001241415A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001353 patent/WO2001055206A1/en not_active Application Discontinuation
- 2001-01-17 CA CA002392757A patent/CA2392757A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001336 patent/WO2001055204A1/en active Search and Examination
- 2001-01-17 AU AU2001241406A patent/AU2001241406A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001356 patent/WO2001055173A2/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001330 patent/WO2001055447A1/en active Search and Examination
- 2001-01-17 CA CA002392398A patent/CA2392398A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001350 patent/WO2001055350A1/en active Search and Examination
- 2001-01-17 CA CA002395666A patent/CA2395666A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001309 patent/WO2001055308A2/en active Search and Examination
- 2001-01-17 CA CA002395738A patent/CA2395738A1/en not_active Withdrawn
- 2001-01-17 CA CA002395654A patent/CA2395654A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001355 patent/WO2001055207A1/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001240 patent/WO2001055302A2/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001357 patent/WO2001055208A1/en not_active Application Discontinuation
- 2001-01-17 AU AU2001241410A patent/AU2001241410A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001312 patent/WO2001054733A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001339 patent/WO2001055320A2/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001314 patent/WO2001055310A2/en active Search and Examination
- 2001-01-17 CA CA002395295A patent/CA2395295A1/en not_active Withdrawn
- 2001-01-17 CA CA002392751A patent/CA2392751A1/en not_active Abandoned
- 2001-01-17 AU AU2001241408A patent/AU2001241408A1/en not_active Abandoned
- 2001-01-17 CA CA002395671A patent/CA2395671A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001308 patent/WO2001055364A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001340 patent/WO2001055321A2/en active Search and Examination
- 2001-01-17 CA CA002394039A patent/CA2394039A1/en not_active Abandoned
- 2001-01-17 CA CA002395693A patent/CA2395693A1/en active Pending
- 2001-01-17 CA CA002395699A patent/CA2395699A1/en active Pending
- 2001-01-17 WO PCT/US2001/001311 patent/WO2001055309A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001327 patent/WO2001055203A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001343 patent/WO2001055323A2/en active Search and Examination
- 2001-01-17 CA CA002393002A patent/CA2393002A1/en not_active Withdrawn
- 2001-01-17 CA CA002395885A patent/CA2395885A1/en not_active Withdrawn
- 2001-01-17 CA CA002398411A patent/CA2398411A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001239 patent/WO2001055301A2/en active Search and Examination
- 2001-01-17 CA CA002395849A patent/CA2395849A1/en active Pending
- 2001-01-17 AU AU2001241412A patent/AU2001241412A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001310 patent/WO2001055387A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001354 patent/WO2001057182A2/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001338 patent/WO2001055367A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001359 patent/WO2001055328A2/en active Application Filing
- 2001-01-17 WO PCT/US2001/001313 patent/WO2001055200A1/en active Search and Examination
- 2001-01-17 CA CA002395403A patent/CA2395403A1/en not_active Withdrawn
- 2001-01-17 CA CA002395827A patent/CA2395827A1/en not_active Withdrawn
- 2001-01-17 CA CA002393652A patent/CA2393652A1/en not_active Withdrawn
- 2001-01-17 AU AU2001241414A patent/AU2001241414A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001335 patent/WO2001055319A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001325 patent/WO2001055202A1/en active Search and Examination
- 2001-01-17 CA CA002392438A patent/CA2392438A1/en not_active Abandoned
- 2001-01-17 AU AU2001241409A patent/AU2001241409A1/en not_active Abandoned
- 2001-01-17 AU AU2001241417A patent/AU2001241417A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001337 patent/WO2001055205A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001352 patent/WO2001055327A2/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001328 patent/WO2001055316A2/en active Search and Examination
- 2001-01-17 AU AU2001250770A patent/AU2001250770A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001341 patent/WO2001055322A2/en active Search and Examination
- 2001-01-17 CA CA002395872A patent/CA2395872A1/en not_active Withdrawn
- 2001-01-17 CA CA002395787A patent/CA2395787A1/en not_active Withdrawn
- 2001-02-05 AU AU4313701A patent/AU4313701A/en active Pending
- 2001-02-08 AU AU4141101A patent/AU4141101A/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001250770A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001237944A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001237953A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001239726A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001237948A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001241403A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001237946A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001241411A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001230958A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001239728A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001236460A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001236459A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001241419A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001243137A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001247190A1 (en) | Nucleic acids, proteins, and antibodies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| CFP | Corrected version of a pamphlet front page | ||
| CR1 | Correction of entry in section i |
Free format text: PAT. BUL. 31/2001 UNDER "PUBLISHED" ADD "SEQUENCE LISTING PART OF DESCRIPTION PUBLISHED SEPARATELY IN ELECTRONIC FORM AND AVAILABLE UPON REQUEST FROM THE INTERNATIONAL BUREAU." |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2397407 Country of ref document: CA |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2001912663 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 2001912663 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| NENP | Non-entry into the national phase |
Ref country code: JP |